Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

Tyler Knight,1 T Christopher Bond,1 Breanna Popelar,2 Li Wang,3 John W Niewoehner,4 Kathryn Anastassopoulos,1 Michael Philbin4 1Covance Market Access Services Inc., Gaithersburg, MD, 2Xcenda, LLC, Palm Harbor, FL, 3STATinMED Research, Ann Arbor, MI, 4Mallinckrodt, LLC, Hazelwood, MO, USA Ba...

Full description

Bibliographic Details
Main Authors:	Knight T, Bond TC, Popelar B, Wang L, Niewoehner JW, Anastassopoulos K, Philbin M
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-05-01
Series:	ClinicoEconomics and Outcomes Research
Subjects:	dermatomyositis polymyositis medical resource use repository adrenocorticotropic hormone
Online Access:	https://www.dovepress.com/medical-resource-utilization-in-dermatomyositispolymyositis-patients-t-peer-reviewed-article-CEOR

Similar Items

Polymyositis and dermatomyositis: Disease spectrum and classification
by: Siba P Raychaudhuri, et al.
Published: (2012-01-01)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
by: Marilda Guimarães Silva, et al.
Published: (2018-02-01)

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
by: Shimojima Yasuhiro, et al.
Published: (2012-11-01)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
by: Takuya Hirai, et al.
Published: (2018-01-01)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.
by: Agnieszka Trybuch, et al.
Published: (2023-07-01)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
by: mei liu, et al.
Published: (2023-11-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

Muscle biopsies in dermatomyositis and polymyositis: practical relevance of analyzing different levels of histological sections of the same muscular compartment
by: Monica T. M. Diaz, et al.
Published: (2017-06-01)

Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach
by: Ha-Neul Jeong, et al.
Published: (2023-12-01)

Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia
by: Sellami Khadija, et al.
Published: (2018-12-01)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
by: Tao Liu, et al.
Published: (2017-01-01)

18F-FDG PET/CT in patients with polymyositis/dermatomyositis: correlation with serum muscle enzymes
by: Hanae Arai-Okuda, et al.
Published: (2020-08-01)

Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis
by: Zoltan Griger, et al.
Published: (2020-09-01)

KL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease
by: Mayada Khalil, et al.
Published: (2023-12-01)

Prevalence of hearing loss, tinnitus, vertigo and sudden deafness among patients with polymyositis and dermatomyositis
by: Shih-Han Hung, et al.
Published: (2024-03-01)

Clinical Characteristics and Associated Factors for Infection and in-Hospital Mortality in Inpatients with Polymyositis/Dermatomyositis in China: A Retrospective Study
by: Lao M, et al.
Published: (2023-01-01)

Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis
by: Joan Raouf, et al.
Published: (2018-05-01)

Involvement of YKL-40-positive macrophages commonly identified in polymyositis and dermatomyositis in the pathogenesis of myositis: a retrospective study
by: Kazuteru Noguchi, et al.
Published: (2024-01-01)

Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2014-05-01)

Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
by: Juyoung Yoo, et al.
Published: (2021-03-01)

Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis
by: Sung Soo Ahn, et al.
Published: (2022-04-01)

Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis
by: Li Y, et al.
Published: (2018-01-01)

Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis/dermatomyositis: a 2-year longitudinal study
by: Andrea Péter, et al.
Published: (2022-09-01)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
by: Stefano Palmucci, et al.
Published: (2022-11-01)

Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis—A Retrospective Cohort Analysis
by: Kassem Sharif, et al.
Published: (2022-11-01)

Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study
by: Jang Woo Ha, et al.
Published: (2023-10-01)

Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
by: Gilmara Franco da Cunha, et al.
Published: (2013-05-01)

T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis
by: Yasuhiro Shimojima, et al.
Published: (2017-11-01)

Paraneoplastic dermatomyositis associated with urothelial cancer: report of a case and systematic review of the literature
by: Josep Sabaté-Ortega, et al.
Published: (2023-10-01)

Dermatomiosite e polimiosite: da imunopatologia à imunoterapia (imunobiológicos) Dermatomyositis and polymyositis: from immunopathology to immunotherapy (immunobiologics)
by: Samuel Katsuyuki Shinjo, et al.
Published: (2013-02-01)

Thymus variants on imaging of patients with primary Sjögren’s syndrome and polymyositis/dermatomyositis: clinical and immunological significance
by: Okinori Murata, et al.
Published: (2023-01-01)

Pyomyositis Secondary to Localized Cellulitis in a Dermatomyositis Patient: A Case Report and Review of Infectious Complications in Dermatomyositis
by: Zhang X, et al.
Published: (2023-08-01)

T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients
by: Miranda Houtman, et al.
Published: (2018-08-01)

Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
by: Yaogui Ning, et al.
Published: (2019-11-01)

Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
by: Fernando Henrique Carlos de Souza, et al.
Published: (2018-09-01)

Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis
by: Chenhang Ma, et al.
Published: (2024-03-01)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01)

Subcutaneous Emphysema, Pneumomediastinum and Pneumothorax in a Patient with Dermatomyositis
by: Mehdi Bakhsaee, et al.
Published: (2017-03-01)

The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature
by: S. Barsotti, et al.
Published: (2018-07-01)

A Narrative Review of Acthar Gel for the Treatment of Myositis
by: Tanya Chandra, et al.
Published: (2023-03-01)